Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Caballero

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Leukemia|August 15, 2000
The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantationR López-Pérez, R García-Sanz, D González, et al.
Bone Marrow Transplantation|March 8, 2016
Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDSJ De La Serna, J Sanz, A Bermúdez, et al.
Leukemia & Lymphoma|December 29, 2004
CD34 + cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantationM Díez-Campelo, J A Pérez-Simón, E M Ocio, et al.
Haematologica|May 9, 1998
Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtypeR García-Sanz, M Vargas Montero, M Gonzalez Díaz, et al.
British Journal of Haematology|December 12, 2001
Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre studyR Martino, M D Caballero, C Canals, et al.
Bone Marrow Transplantation|January 20, 2004
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trialM Gómez-Núñez, R Martino, M D Caballero, et al.
Bone Marrow Transplantation|October 6, 1997
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factorsM D Caballero, V Rubio, J Rifon, et al.
Bone Marrow Transplantation|April 21, 2001
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimensA Salar, J Sierra, M Gandarillas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experienceJ Rodríguez, M D Caballero, A Gutiérrez, et al.
Haematologica|October 17, 2001
Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantationR Martino, M Rovira, E Carreras, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Leukemia|August 15, 2000
The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantationR López-Pérez, R García-Sanz, D González, et al.
Bone Marrow Transplantation|March 8, 2016
Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDSJ De La Serna, J Sanz, A Bermúdez, et al.
Leukemia & Lymphoma|December 29, 2004
CD34 + cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantationM Díez-Campelo, J A Pérez-Simón, E M Ocio, et al.
Haematologica|May 9, 1998
Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtypeR García-Sanz, M Vargas Montero, M Gonzalez Díaz, et al.
British Journal of Haematology|December 12, 2001
Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre studyR Martino, M D Caballero, C Canals, et al.
Bone Marrow Transplantation|January 20, 2004
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trialM Gómez-Núñez, R Martino, M D Caballero, et al.
Bone Marrow Transplantation|October 6, 1997
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factorsM D Caballero, V Rubio, J Rifon, et al.
Bone Marrow Transplantation|April 21, 2001
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimensA Salar, J Sierra, M Gandarillas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experienceJ Rodríguez, M D Caballero, A Gutiérrez, et al.
Haematologica|October 17, 2001
Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantationR Martino, M Rovira, E Carreras, et al.
Pageof 8